Identification of skeletal muscle-specific mechanisms of CREB-CRTC regulation could allow development of novel therapeutic strategies to target this pathway to improve muscle health and avoid off-target effects in individuals with metabolic disease or cancer. This evidence concerns the gene CALR and cancer.